plasma caffeine concentration determined 12 h after administration of the test dosage discriminated best between patients with cirrhosis ( 5.4 +/- 1.6 mumol/l ) , patients with non-cirrhotic liver disease ( 2.0 +/- 1.4 mumol/l ) and healthy volunteers ( 0.8 +/- 0.2 mumol/l ) .
C0023890
cirrhosis
C0023895
liver disease